author-photo

Robert D. McQuade

Princeton University
Schering-Plough
Bristol-Myers Squibb

257

Papers

11684

Citations

Citation Trend

Filter By

Papers (257) Sort By

Journal Conference Others

Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants (European Journal of Clinical Pharmacology, (2020), 10.1007/s00228-020-03021-9)

2021 European Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole.

2021
Show All
- Source
- Cite
- Save
Citations (1)
The Dopamine D2 Receptor Partial Agonist Antipsychotics, Aripiprazole, and Brexpiprazole

2021
Show All
- Source
- Cite
- Save
Citations (0)
An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants.

2020 European Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (2)
A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

2019 Journal of Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (9)
Efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer's dementia: two 12-week, randomized, double-blind, placebo-controlled trials

2019 American Journal of Geriatric Psychiatry
Show All
- Source
- Cite
- Save
Citations (25)
Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

2018 Current Medical Research and Opinion
Show All
- Source
- Cite
- Save
Citations (23)
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder

2018 International Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (14)
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies

2018 International Clinical Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (2)
The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study

2018 Journal of Affective Disorders
Show All
- Source
- Cite
- Save
Citations (7)